1. Home
  2. DAN vs LIVN Comparison

DAN vs LIVN Comparison

Compare DAN & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dana Incorporated

DAN

Dana Incorporated

N/A

Current Price

$36.18

Market Cap

3.3B

ML Signal

N/A

Logo LivaNova PLC

LIVN

LivaNova PLC

N/A

Current Price

$71.32

Market Cap

3.5B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DAN
LIVN
Founded
1904
1987
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.3B
3.5B
IPO Year
1998
2015

Fundamental Metrics

Financial Performance
Metric
DAN
LIVN
Price
$36.18
$71.32
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$35.00
$69.50
AVG Volume (30 Days)
1.4M
769.5K
Earning Date
05-18-2026
06-01-2026
Dividend Yield
1.34%
N/A
EPS Growth
N/A
N/A
EPS
0.97
N/A
Revenue
$10,284,000,000.00
N/A
Revenue This Year
N/A
$8.13
Revenue Next Year
$3.03
$6.53
P/E Ratio
$36.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.11
$32.48
52 Week High
$36.09
$70.60

Technical Indicators

Market Signals
Indicator
DAN
LIVN
Relative Strength Index (RSI) 78.51 67.51
Support Level $18.71 $61.50
Resistance Level N/A N/A
Average True Range (ATR) 1.18 2.31
MACD 0.12 0.31
Stochastic Oscillator 93.20 84.70

Price Performance

Historical Comparison
DAN
LIVN

About DAN Dana Incorporated

Dana Inc is engaged in the designing and manufacturing of efficient propulsion and energy-management solutions that power vehicles and machines in all mobility markets across the globe. The company has four operating segments: Light Vehicles, Power Technologies, Commercial Vehicle, and Off-Highway. The Light Vehicles segment generates the majority portion of revenue by providing products to support light vehicle OEMs. Its products are designed for light trucks, SUVs, CUVs, vans, and passenger cars.

About LIVN LivaNova PLC

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.

Share on Social Networks: